Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice

BACKGROUND: Pregnant women are at increased risk of thrombotic adverse events. Plasma derived immune globulin (IG) products, which are used in pregnancy for various indications, may contain procoagulant impurity activated coagulation factor XI (FXIa). Procoagulant IG products have been associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yanqun, Liang, Yideng, Parunov, Leonid, Despres, Daryl, Eckhaus, Michael, Scott, Dorothy, Ovanesov, Mikhail, Struble, Evi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648396/
https://www.ncbi.nlm.nih.gov/pubmed/33292285
http://dx.doi.org/10.1186/s12959-020-00245-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648396/
https://www.ncbi.nlm.nih.gov/pubmed/33292285
http://dx.doi.org/10.1186/s12959-020-00245-8

Ejemplares similares